新一代疫苗 2679条(本栏目收费,不能显示细节,电话13136136841)
therapeutic vaccines,523 523
T-cell activation by superantigens,174 174
T-cell responses in early life challenges to induction of,230 230
factors limiting to,230,231 231
Tetraspanin integral membrane protein,812 812
Th cell populations,174 174
T helper cells characterization,517 517
cytokine production by,518 518
Therapeutic vaccines,294 294
role as adjunctive therapy against TB,523 523
Thrombospondin-related adhesive protein(TRAP),398,752,753 753
Th1-type adjuvants,614 614
Th1-type cell-mediated immunity,265 265
enhancement of measles and respiratory syncytial virus disease,133 133
osp A Lyme disease vaccine,134,135 135
seed lots and standardization of manufacturing,133 133
vaccine-associated paralytic polio,133 133
vaccine-derived polio outbreaks,133 133
vaccine purity,132,133 133
whole-cell pertussis vaccines,133 133
safety lessons from the history of vaccine development vaccine safety rotavirus vaccines,133,134 134
alternative approaches,284,286 286
classification system for,286 286